TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
198,164
|
157,132
|
161,726 |
| Financial expenses |
2,488
|
2,335
|
3,130 |
| Earnings before taxes |
13,354
|
1,865
|
4,445 |
| Total assets |
128,108
|
108,090
|
120,509 |
| Current assets |
68,863
|
41,007
|
48,162 |
| Current liabilities |
53,136
|
40,754
|
44,293 |
| Equity capital |
46,967
|
36,948
|
37,912 |
| - share capital |
347
|
353
|
378 |
| Employees (average) |
88
|
86 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.7%
|
34.2%
|
31.5% |
| Turnover per employee |
2,252
|
1,827 | |
| Profit as a percentage of turnover |
6.7%
|
1.2%
|
2.7% |
| Return on assets (ROA) |
12.4%
|
3.9%
|
6.3% |
| Current ratio |
129.6%
|
100.6%
|
108.7% |
| Return on equity (ROE) |
28.4%
|
5.0%
|
11.7% |
| Change turnover |
43,815
|
6,121
|
-21,633 |
| Change turnover % |
28%
|
4%
|
-12% |
| Chg. No. of employees | 2 | ||
| Chg. No. of employees % | 2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.